1-3
2026
影响因子区间
143天
平台估算
6%
2025
中国作者发文占比
1969 USD
收费
期刊简介:Therapeutic Innovation & Regulatory Science (TIRS) is the official scientific journal of DIA that strives to advance medical product discovery, development, regulation, and use through the publication of peer-reviewed original and review articles, commentaries, and letters to the editor across the spectrum of converting biomedical science into practical solutions to advance human health.The focus areas of the journal are as follows: Biostatistics Clinical Trials Product Development and Innovation Global Perspectives Policy Regulatory Science Product Safety Special Populations
【译文】治疗创新与监管科学(TIRS)是DIA的官方科学期刊,致力于通过发表同行评审的原创和综述文章、评论和编辑信件,在将生物医学科学转化为促进人类健康实用解决方案的整个范围内,推进医疗产品发现、开发、监管和使用。该期刊的关注领域包括:生物统计学、临床试验、产品开发与创新、全球视角、政策、监管科学、产品安全、特殊人群

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |